The Centers for Disease Control and Prevention wants to evaluate new technologies that improve rapid influenza diagnostic testing and supplement national laboratory-based surveillance for flu infections, according to a notice issued on January 28.
In particular, CDC wants to test new or improved point of care diagnostic tests that can transmit results electronically through wireless technology, bringing more timely diagnoses of flu and other respiratory conditions, the notice states.
The tests may range from high complexity molecular assays providing genetic sequence information to point of care-type tests that facilitate more timely diagnosis of human influenza infections and/or other respiratory pathogen infections in ambulatory and emergency room health care practices. Assays should present sensitivity and specificity higher than currently available products.
Inquiries and proposals may be submitted until Dec. 31, 2015. Information submitted will remain confidential as permitted under relevant federal laws, CDC says. More information is available here.
Register or login for access to this item and much more
All Health Data Management content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access